AVR 3.51% $15.13 anteris technologies ltd

Ann: DurAVR first successful implantation Valve-in-Valve, page-13

  1. 5,154 Posts.
    lightbulb Created with Sketch. 875
    Hi all -- what a brilliant ann., from left field.

    On first read I like these parts,:- my print -expanded -underlining (a problem) and- italics ........

    These hemodynamic results are not seen with currently available products, which is important as there is a large need for a valve that can offer optimal hemodynamic performance in the valve-in-valve setting,......

    '..................Additionally, despite this being an incredibly complex case, using
    Anteris’ ComASUR™
    delivery system and deploying the valve was remarkably easy
    .The unique design of DurAVR™,
    including the low frame height and the singlepiece design, makes the valve well-suited to address the needs of valve-in-valve patients”.

    .
    Chris Meduri, Anteris Technologies CMO, commented:
    “This successful procedure further validates our extensive pre-clinical work in valve-in-valve as
    well as our extensive clinical experience in native aortic stenosis. This signals the
    viability of a
    purpose-built valve designed to achieve life-saving outcomes in a
    patient population currently

    treated with tradeoffs in mind. Eliminating that compromise would be widely beneficia
    lto a rapidly
    growing population of patients whose current valve is failing
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$15.13
Change
-0.550(3.51%)
Mkt cap ! $321.0M
Open High Low Value Volume
$15.70 $15.94 $15.02 $237.1K 15.21K

Buyers (Bids)

No. Vol. Price($)
1 165 $15.12
 

Sellers (Offers)

Price($) Vol. No.
$15.36 251 3
View Market Depth
Last trade - 13.59pm 19/08/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.